Terumo Corporation
OTCPK:TRUM.F 株式レポート
Terumo マネジメント Terumoの CEO はHikaru Samejimaで、 Apr2024年に任命され、 の在任期間は 1 年未満です。 は、会社の株式の0.003%を直接所有しており、その価値は$ 765.92K 。経営陣と取締役会の平均在任期間はそれぞれ0.8年と3.1年です。
主要情報 CEO給与比率 n/a CEO在任期間 less than a year CEOの所有権 0.003% 経営陣の平均在職期間 less than a year 取締役会の平均在任期間 3.1yrs
経営陣の近況 Shinjiro Sato to Leave as CEO of Terumo Corporation on April 1, 2024
Terumo Corporation, Annual General Meeting, Jun 27, 2023 May 16
Terumo Corporation, Annual General Meeting, Jun 22, 2022 Feb 10
すべての更新を表示
Terumo Corporation to Report Q2, 2025 Results on Nov 07, 2024 Sep 25 Terumo Corporation (TSE:4543) announces an Equity Buyback for 15,000,000 shares, representing 1.01% for ¥30,000 million. Aug 30
Terumo Corporation to Report Q1, 2025 Results on Aug 08, 2024 Jun 02
Terumo Cardiovascular Announces 510(K) Clearance for the CDI Oneview™? Monitoring System May 29
Terumo Corporation to Report Fiscal Year 2024 Results on May 14, 2024 Mar 17
Terumo Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 Feb 09 Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 Shinjiro Sato to Leave as CEO of Terumo Corporation on April 1, 2024
Terumo Corporation to Report Q3, 2024 Results on Feb 07, 2024 Dec 03
Terumo Corporation to Report Q2, 2024 Results on Nov 14, 2023 Oct 01
Terumo Corporation (TSE:4543) announces an Equity Buyback for 5,000,000 shares, representing 0.67% for ¥20,000 million. Aug 10
Terumo Corporation to Report Q1, 2024 Results on Aug 09, 2023 Jun 21 Terumo Corporation Announces Fiscal Year-End Dividend for the Fiscal Year Ended March 31, 2023, Payable on June 28, 2023; Provides Second Quarter-End Dividend Guidance for the Fiscal Year Ending March 31, 2024 and Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024
Terumo Corporation, Annual General Meeting, Jun 27, 2023 May 16 Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023 Terumo Corporation Announces Dividend for the Second Quarter End of Fiscal Year 2023, Commences Dividend Payments on December 5, 2022; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023
Terumo Corporation to Report Q3, 2023 Results on Nov 10, 2023 Nov 10
Terumo Corporation to Report Q2, 2023 Results on Nov 10, 2022 Sep 28
Mitsui DM Sugar Holdings Co.,Ltd. (TSE:2109) agreed to acquire Enteral formula business of Terumo Corporation from Terumo Corporation (TSE:4543). Sep 09
NUTRI Co.,Ltd. entered into an agreement to acquire Nutritional food and related product assets of Terumo Corporation. Sep 08 Terumo Corporation Provides Dividend Guidance for the Second Quarter of Year Ending March 31, 2023
Terumo Announces Change in Indication for Dexcom G6 CGM System in Japan May 16 Terumo Corporation (TSE:4543) announces an Equity Buyback for 15,000,000 shares, representing 1.98% for ¥50,000 million.
Terumo Corporation to Report Fiscal Year 2022 Results on May 12, 2022 Apr 08
Terumo Corporation, Annual General Meeting, Jun 22, 2022 Feb 10 Terumo Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022 Terumo Corporation Provides Dividend Guidance for the Year Ending March 2022
Terumo Corporation (TSE:4543) signed definitive agreement to acquire All Assets from Health Outcomes Sciences, Inc. Feb 25
Terumo Corporation Announces Clinical Study in Japan for Product Using Terumo's Automated Injection Device Developed in Collaboration with Kyowa Kirin Co., Ltd Feb 08
Terumo Corporation Revises Earnings Guidance for the Fourth Quarter of Fiscal 2021 Feb 06
IceCure Medical Ltd Inks Expanded Distribution Agreement with Terumo Corporation for Thailand Jan 06
Terumo Corporation to Report Q3, 2021 Results on Feb 04, 2021 Dec 23
Diabeloop SA. and Terumo Corporation Enter into Joint Development Agreement with Exclusive Distribution Right for Dblg1 Automated Insulin Delivery Solution in Japanese Market Nov 17
IceCure Medical Ltd Expands Strategic Collaboration with Terumo Corporation, New Commercial Distribution Agreement Potentially Valued at over $7.0 Million Oct 06
Terumo Corporation to Report Q2, 2021 Results on Nov 05, 2020 Sep 27
Terumo Corporation (TSE:4543) acquired ReThink Medical, Inc. Aug 25
Terumo Corporation (TSE:4543) acquired remaining 80.1% stake in Quirem Medical B.V. for $45 million. Jul 30 Terumo Corporation to Report Q1, 2021 Results on Aug 06, 2020 Jun 29
CEO（最高経営責任者 Mr. Hikaru Samejima served as Director of Terumo Corporation since February 7, 2024 until June 26, 2024 and serves as its Representative Director since June 26, 2024. He serves as President and CEO of Teru ... Show more
リーダーシップ・チーム 名称 ポジション 在職期間 報酬 所有権 Chairman of the Board & Group Managing Executive Officer 14.4yrs JP¥137.00m データなし Representative Director less than a year データなし 0.0027% $ 765.9k CFO, CIO less than a year データなし データなし CTO, GM of DX Promotion Dept. R&D Division and Executive Officer less than a year データなし データなし Executive Officer 8.6yrs データなし データなし Chief Human Resources Officer & Group Executive Officer 1.8yrs データなし データなし Director & Group Managing Executive Officer no data データなし 0.0023% $ 650.7k Group Managing Executive Officer less than a year データなし データなし Group Senior Managing Executive Officer & Director no data データなし データなし Group Managing Executive Officer less than a year データなし データなし Director & Group Managing Executive Officer 1.6yrs データなし 0.0026% $ 754.4k Group Senior Managing Executive Officer less than a year データなし データなし
もっと見る
経験豊富な経営陣: TRUM.Fの経営陣は 経験豊富 とはみなされません ( 0.8年の平均在職年数)。これは新しいチームを示唆しています。
取締役 名称 ポジション 在職期間 報酬 所有権 Chairman of the Board & Group Managing Executive Officer 14.4yrs JP¥137.00m データなし Representative Director less than a year データなし 0.0027% $ 765.9k Director & Group Managing Executive Officer 2.8yrs データなし 0.0023% $ 650.7k Group Senior Managing Executive Officer & Director less than a year データなし データなし Director & Group Managing Executive Officer 1.4yrs データなし 0.0026% $ 754.4k Independent Director 5.4yrs データなし データなし Independent Outside Director 4.4yrs データなし 0.00029% $ 83.5k Director 3.4yrs データなし 0.0025% $ 711.2k Substitute Director 2.4yrs データなし データなし Independent Outside Director 5.4yrs データなし 0.00037% $ 106.5k Independent Outside Director 3.4yrs データなし 0.00011% $ 31.7k Independent Director less than a year データなし データなし
もっと見る
経験豊富なボード: TRUM.Fの 取締役会 は 経験豊富 であると考えられます ( 3.1年の平均在任期間)。
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}